Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSweating more on Mounjaro is something a number of people notice, particularly in the first few weeks of treatment. It isn't listed as a common side effect in the Mounjaro SmPC, but the indirect reasons it happens are well understood — and for most people the decision is simply whether to adjust a few habits rather than whether to stop. Mounjaro (tirzepatide) is a prescription-only medicine requiring clinical assessment before it can be prescribed, and any symptom that feels persistent or severe should be discussed with your prescribing team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Check the official prescribing information and you won't find hyperhidrosis (excess sweating) in the common side-effect column. The NHS tirzepatide page lists the gut-focused effects (nausea, vomiting, diarrhoea, constipation, indigestion) as the ones most people encounter. So why do a meaningful number of Mounjaro users report sweating anyway?
The short answer is that several of the medicine's well-documented effects produce sweating as a downstream result. Nausea, for instance, triggers the autonomic nervous system in ways that cause clamminess and cold sweats. This is the same mechanism behind the sweat that accompanies travel sickness. If you're feeling queasy after a dose increase, some degree of sweating often comes with it.
Separately, tirzepatide alters glucose metabolism significantly. People who are also managing type 2 diabetes (or who are on the borderline of low blood sugar) may experience hypoglycaemic episodes that produce sudden sweating, shaking and a rapid heartbeat. This combination needs prompt attention. For context on how tirzepatide works at the metabolic level, the question of whether Mounjaro raises calorie burn is worth reading alongside this one, and if you're curious whether the medicine affects perspiration more directly, whether you sweat more on Mounjaro is covered in detail elsewhere on this site.
The decision at this point is whether your sweating traces back to one of these causes. That diagnosis shapes everything that follows.
The timing of new or worsened sweating is the most useful signal. A pattern our prescribers hear fairly regularly: sweating becomes more noticeable in the week or two after a dose step up, then fades as the body acclimates. The mechanism here is likely the metabolic and hormonal adjustment the medicine creates, shifts in appetite hormones, gastric emptying rate and insulin sensitivity don't happen silently.
Night sweats sit in a slightly different category. They can reflect disrupted sleep quality (common when GI discomfort disturbs rest), temperature dysregulation during periods of rapid weight loss, or (in women around perimenopause) an interaction between changing oestrogen levels and the physiological upheaval treatment brings. None of these make night sweats inevitable, and most resolve without any change to treatment.
Practical adjustments that people find useful: lighter bedding, keeping the room cooler, and staying well hydrated through the day. Dehydration from nausea or reduced appetite can itself cause the body to thermoregulate less efficiently. If you keep your Mounjaro pen in the fridge door, that's also a good moment to make sure you're drinking enough water before the pen goes back in.
If night sweats are severe, recurrent, or accompanied by weight loss that seems faster than expected, tell your prescriber. The fuller picture of Mounjaro and sweating covers the less common presentations worth flagging.
Most sweating on tirzepatide is a nuisance, not a warning. But three presentations deserve faster attention.
First: sweating combined with dizziness, shakiness, a racing heart and sudden hunger points strongly to hypoglycaemia. This is most relevant for people also prescribed insulin or a sulphonylurea. If you are, your prescriber should have given you a plan for this before starting, and if you're unsure about that plan, our clinical team is reachable seven days a week.
Second: profuse sweating alongside severe, persistent stomach pain (particularly if the pain radiates toward the back) is one of the signs the MHRA's January 2026 Drug Safety Update flagged for acute pancreatitis. That update specifically asked patients on GLP-1 medicines to seek urgent medical care for this combination. Don't wait to report it.
Third: an allergic reaction can present with sweating alongside a rash, swelling or breathing difficulty. Again, urgent care rather than watching and waiting.
For everything else, the MHRA's Yellow Card scheme is the right place to log unexpected symptoms, it's how post-market safety data for tirzepatide is built. You don't need a GP to submit a report.
As weight falls and activity typically increases, the body's thermoregulation changes. People who were largely sedentary before treatment and are now walking more or returning to exercise will simply sweat more, that's physiology working correctly, not a side effect. The guidance on eating well during treatment is relevant here too: staying adequately nourished, particularly on protein and fluid, helps the body manage the energy and temperature shifts treatment brings.
If reduced appetite has led to eating very little (something that can happen, especially at higher doses) the resulting caloric restriction can cause a degree of metabolic stress that occasionally manifests as disproportionate sweating. Your prescriber can help calibrate appetite management so that the reduction is sustainable rather than severe.
The broader treatment picture, from how Mounjaro works to what eligibility looks like, is covered on the Mounjaro treatment overview. And if you're at the stage of weighing up a private consultation, you can also see what private Mounjaro treatment typically costs in the UK, with a clear breakdown of what legitimate pricing includes. For most people wondering whether sweating is a reason to reconsider treatment, the answer is no, but getting that confirmed by a prescriber who knows your full history is worth more than any general reassurance. Start your free consultation and our prescribers can review your individual picture the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.